Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Renée S. Martin
Observed names:
Martin, R.S.,
R S Martin,
R. Martin,
R.S. Martin,
Renee Martin,
Renee S Martin,
Renee S. Martin
show all 7
Institution:
TiVo (United States)
Observed institutions:
Roche (United States),
Associação de Assistência à Criança Deficiente,
TiVo (United States),
Anthera Pharmaceuticals (United States),
University of Pennsylvania
ORCID:
0000-0002-3975-1480
Observed ORCID:
0000-0002-3975-1480
OpenAlex ID:
A5024571354
A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC study
2014
·
R A Furie
, G Leon
, et al.
·
Annals of the Rheumatic Diseases
·
179
Phase III trial results with blisibimod, a selective inhibitor of B-cell activating factor, in subjects with systemic lupus erythematosus (SLE): results from a randomised, double-blind, placebo-controlled trial
2018
·
Joan T Merrill
, William R Shanahan
, et al.
·
Annals of the Rheumatic Diseases
·
166
PDF
AF‐353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist
2010
·
Joel R Gever
, Rothschild Soto
, et al.
·
British Journal of Pharmacology
·
147
PDF
Selective 5HT2A and 5HT6 Receptor Antagonists Promote Sleep in Rats
2008
·
Stephen R. Morairty
, Linda Hedley
, et al.
·
SLEEP
·
125
PDF
Effects of cannabinoid receptor ligands on psychosis-relevant behavior models in the rat
2003
·
Renee S. Martin
, Robert L. Secchi
, et al.
·
Psychopharmacology
·
92
The Survival Motor Neuron Protein Forms Soluble Glycine Zipper Oligomers
2012
·
Renee Martin
, Kushol Gupta
, et al.
·
Structure
·
82
PDF
Effects of cannabinoid receptor agonists on neuronally‐evoked contractions of urinary bladder tissues isolated from rat, mouse, pig, dog, monkey and human
2000
·
R S Martin
, L A Luong
, et al.
·
British Journal of Pharmacology
·
79
PDF
Antidepressants Targeting the Serotonin Reuptake Transporter Act via a Competitive Mechanism
2008
·
Subbu Apparsundaram
, Daniel J. Stockdale
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
61
A 5-HT4 Receptor Transmembrane Network Implicated in the Activity of Inverse Agonists but Not Agonists
2002
·
Lara Joubert
, Sylvie Claeysen
, et al.
·
Journal of Biological Chemistry
·
48
PDF
Highly potent, non-basic 5-HT6 ligands. Site mutagenesis evidence for a second binding mode at 5-HT6 for antagonism
2010
·
Ralph N. Harris
, Russel S. Stabler
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
45
Assessments of fatigue and disease activity in patients with systemic lupus erythematosus enrolled in the Phase 2 clinical trial with blisibimod
2016
·
M A Petri
, R S Martin
, et al.
·
Lupus
·
42
3,4-Dihydro-2H-benzo[1,4]oxazine derivatives as 5-HT6 receptor antagonists
2007
·
Shu-Hai Zhao
, Jacob Berger
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
41
A PHASE III TRIAL OF ETANERCEPT vs METHOTREXATE (MTX) IN EARLY RHEUMATOID ARTHRITIS (ENBREL ERA TRIAL)
2000
·
Eric Ruderman
, Renée S. Martin
, et al.
·
リウマチ
·
38
Oligomeric Properties of Survival Motor Neuron·Gemin2 Complexes
2015
·
Kushol Gupta
, Renee Martin
, et al.
·
Journal of Biological Chemistry
·
36
PDF
Kinetic and Thermodynamic Assessment of Binding of Serotonin Transporter Inhibitors
2008
·
Renee S. Martin
, Robert A. Henningsen
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
31
Blisibimod for treatment of systemic lupus erythematosus: with trials you become wiser
2016
·
Morton A. Scheinberg
, Colin M. Hislop
, et al.
·
Expert Opinion on Biological Therapy
·
18
A comparison of liprotamase, a non-porcine pancreatic enzyme replacement therapy, to porcine extracted pancrelipase in a noninferiority randomized clinical trial in patients with cystic fibrosis
2018
·
Michael W Konstan
, Jeffrey S Wagener
, et al.
·
Clinical Investigation
·
13
PDF
Mechanism of subendocardial cell proliferation in the rat and relevance for understanding drug-induced valvular heart disease in humans
2009
·
Mark R. Fielden
, Mary Hassani
, et al.
·
Experimental and Toxicologic Pathology
·
13
Locus Coeruleus and Noradrenergic Pharmacology in Neurodegenerative Disease
2023
·
Rachel A. Matt
, Renee S. Martin
, et al.
·
Handbook of experimental pharmacology
·
12
Cognitive Effects of Three β-Adrenoceptor Acting Drugs in Healthy Volunteers and Patients with Parkinson’s Disease
2024
·
Pepijn P.N.M. Eijsvogel
, Laura G.J.M. Borghans
, et al.
·
Journal of Parkinson s Disease
·
8
PDF
Characterization of human recombinant α2A‐adrenoceptors expressed in Chinese hamster lung cells using extracellular acidification rate changes
2000
·
S J MacLennan
, P H Reynen
, et al.
·
British Journal of Pharmacology
·
8
Pharmacological Comparison of a Recombinant CB1 Cannabinoid Receptor with Its Ga16 Fusion Product
2002
·
Renée S. Martin
, Paul H. Reynen
, et al.
·
SLAS DISCOVERY
·
7
PDF
AB0412 Exploratory Results from The Bliss and Illuminate Trials Support The Design of The CHABLIS-SC1 Trial, A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study To Evaluate The Efficacy and Safety of Blisibimod Administration in Subjects with Systemic Lupus Erythematosus
2016
·
J.T. Merrill
, V. Strand
, et al.
·
Annals of the Rheumatic Diseases
·
4
Disappearance of cryoproteins in the sera of a patient with SLE after treatment with blisibimod, a novel subcutaneous anti-B cell therapy
2013
·
A. P. F. Golmia
, R. Martin
, et al.
·
Rheumatology
·
4
OP0116 Effects of Blisibimod, a Subcutaneous Inhibitor of B Cell Activating Factor, in Patients with SLE
2013
·
R. Furie
, M. Scheinberg
, et al.
·
Annals of the Rheumatic Diseases
·
4
Show more works
View as search
Works count:
42
Citation count:
1,318
H-index:
16
I10-index:
19
Year
Topic
Type